20 May 2013
Keywords: enbrel, effective, arthritis, says, study, immunex, phase
Article | 23 July 1997
As Immunex' Phase III trial of its novel treatment for rheumatoidarthritis Enbrel (tumor necrosis factor receptor) nears completion, the drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.